# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-000589
Filing Date
2024-04-09
Accepted
2024-04-09 16:12:07
Documents
74
Period of Report
2024-02-29

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | lxrp_10q.htm iXBRL | 10-Q | 942834
2 | EXECUTIVE EMPLOYMENT AGREEMENT | lxrp_ex105.htm | EX-10.5 | 139664
3 | AMENDED AND RESTATED INTELLECTUAL PROPERTY LICENSE AGREEMENT | lxrp_ex106.htm | EX-10.6 | 204021
4 | CERTIFICATION | lxrp_ex311.htm | EX-31.1 | 12056
5 | CERTIFICATION | lxrp_ex312.htm | EX-31.2 | 9497
6 | CERTIFICATION | lxrp_ex321.htm | EX-32.1 | 4206
7 | CERTIFICATION | lxrp_ex322.htm | EX-32.2 | 4339
13 |  | lxrp_ex106img5.jpg | GRAPHIC | 3920
14 |  | lxrp_10qimg19.jpg | GRAPHIC | 1582
15 |  | lxrp_ex106img6.jpg | GRAPHIC | 3960
| Complete submission text file | 0001640334-24-000589.txt |  | 5234442

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20240229.xsd | EX-101.SCH | 47126
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20240229_lab.xml | EX-101.LAB | 275509
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20240229_cal.xml | EX-101.CAL | 45777
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20240229_pre.xml | EX-101.PRE | 233526
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20240229_def.xml | EX-101.DEF | 114995
78 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10q_htm.xml | XML | 792024

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 24832855
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)